Yesterday, Heartland’s Dr. Richard Dolinar and Kendall Antekeier were featured in a Forbes.com article by Henry I. Miller, a physician and molecular biologist at the Hoover Institution at Stanford University, and Jeff Stier, a senior fellow and director for the Risk Analysis Division at the National Center for Public Policy Research.
Miller and Stier give a thorough account of the Centers for Disease Control and Prevention’s new egalitarian and costly decision making process to determine additions to the childhood immunization schedule, including a new meningitis vaccine for infants.
“What has changed since the CDC made elimination of the meningococcal disease a priority in 1999? For one thing, the federal government’s increasing involvement in health care. Every decision made about which vaccine is recommended has a financial component that concerns government officials. According to CDC officials and experts working with the Advisory Committee on Immunization Practices (ACIP), the CDC group that will make a recommendation on the meningitis vaccine, “cost-effectiveness, not just science” will be considered in the decision making process.”
The more government annexes health care policy decisions, the more it dissociates taxpayers from their health care choices. Using cost-effectiveness instead of science to determine health policies is bad for taxpayers and is bad health policy. (Click here to read the full article.)
For more information on this topic, click here to view a recent Policy Tip Sheet from The Heartland Institute. Additional information on consumer health care choices, visit http://heartland.org/issues/health-care.